News Archive
Former Press Releases (PDF)
2008
- December 2008: Cellzome Announces Achievement of First Milestone in Inflammation Alliance with GlaxoSmithKline more ...
- November 2008: Cellzome awarded € 3.85m grant in Germany's High-Tech Initiative
to Fund Top Regional Clusters more ... - October 2008: Translational medicine award to use Kinobeads™ to profile the expressed kinome in early inflammatory arthritis more ...
- September 2008: Cellzome Strengthens Management Team with New Hires from
UCB Celltech more ... - September 2008: GlaxoSmithKline and Cellzome Announce Major Strategic Alliance more ...
- July 2008: Cellzome extends Drug Discovery Collaboration more ...
- April 2008: TAP Technology Originators nominated for title of European Inventor
of the Year 2008 more ... - January 2008: Cellzome appoints Dr. Jane Dancer as VP Business Development more ...
2007 ...
- December 2007: Cellzome Establishes Scientific Advisory Board more ...
- November 2007: Cellzome CEO appointed to the Board of the UK's BioIndustry
Association more ... - August 2007: Cellzome publishes a Powerful 'Finger-Printing' Technology which Identifies Novel Targets for Gleevec™ more ...
- March 2007: Cellzome Receives First Milestone Payment for Alzheimer's Programme from Ortho-McNeil Pharmaceutical, Inc. more ...
- January 2007: Cellzome Announces Extension of Drug Discovery Collaboration in Alzheimer's Disease with Ortho-McNeil Pharmaceutical, Inc. more ...
- January 2007: Cellzome scientists publish novel approach to quantitative proteomics in
Nature Biotechnology more ...
2006 ...
- October 2006: Cellzome Announces further Extension of Molecular Pathway Collaboration more ...
- July 2006: Galapagos and Cellzome in kinase drug discovery collaboration more ...
- July 2006: Cellzome announces Extension of Molecular Pathway Collaboration more ...
- July 2006: Cellzome appoints David Simmons as Chief Scientific Officer more ...
- January 2006: Cellzome and EMBL scientists publish the first genome-wide survey
of protein complexes more ...
2005 ...
- October 2005: Cellzome and Graffinity awarded € 2.2 million grant from
German Ministry of Research and Education more ... - September 2005: Cellzome Concludes Collaboration with Bayer HealthCare more ...
- July 2005: Expansion of Pathway Collaboration with Novartis more ...
- May 2005: Ortho-McNeil Pharmaceutical exercises option to license
Alzheimer's disease compounds more ... - March 2005: Drug Discovery Collaboration in Alzheimer's Disease with
Ortho-McNeil Pharmaceutical more ...
2004 ...
- September 2004: Partnership Agreement with Novartis more ...
- September 2004: Tim Edwards joins Cellzome as CEO more ...
- March 2004: Cellzome Moves UK Facilities to Cambridge, One of Europe’s Biggest
Biotech Hubs more ... - February 2004: A physical and functional map of the human TNF-α/NF-κB signal
transduction pathway. Nature Cell Biology Vol. 6 pp. 97-105 more ...
2003 ...
- December 2003: Cellzome Signs Research Collaboration with Bayer HealthCare AG more ...
- October 2003: Research Collaboration with Johnson & Johnson Pharmaceutical R&D more ...
- March 2003: Cellzome Hits Target on Series C Financing more ...
2002 ...
- September 2002: Cellzome Appoints Dr. David Brown as President and CEO more ...
- January 2002: Cellzome Publishes Novel Approach For The Systematic Use Of
Protein Interaction Maps In Drug Discovery In Nature more ...
